Empowering Biopharma’s Legal Leaders to Maximize Their Impact,
Save on Cost & Drive Business Success

Welcome to the 6th Annual In-House Impact: Biopharma Summit 2025

As the regulatory landscape continues to evolve, 2025 is a pivotal year for legal leaders in biopharma. The 6th In-House Impact: Biopharma Summit is your exclusive opportunity to unite with top legal minds from Takeda, Kura Oncology, Neurocrine Biosciences, and more to tackle today’s most pressing challenges—tariffs, financing, M&A strategy, and beyond.

Tailored for General Counsels and Chief Legal Officers at drug development companies, this intimate, peer-led summit empowers you to elevate legal as a business-critical function. Learn how in-house teams are adapting to economic volatility, harnessing new legal tech, and navigating cross-functional leadership demands, all while building a valuable network of peers.

This is not just another conference. It’s a strategic inflection point. Free to attend for biopharma’s in-house counsel, this event will help you transition from a traditional lawyer to a corporate leader, ready to drive business success.

Meet Your 2025 Expert Speaker Faculty

Darin Lippoldt

Darin Lippoldt

Chief Legal Officer

Neurocrine Biosciences

Guled Adam

Guled Adam

General Counsel

Sobi NA

James Singleton

James Singleton

General Counsel

Numab Therapeutics AG

Rupa Cornell

Rupa Cornell

Vice President & Head Of Counsel, Vaccine Business Unit

Takeda Pharmaceutical

Tamara Tompkins

Tamara Tompkins

Chief Legal Officer

Insitro

Hear from Our Past Attendees

“Insights were immediately actionable”

“The opportunity for undirected communication with peers within the panel discussions and informally at breaks led to the sharing of experiences and insights that were immediately actionable and facilitated networking.”

Umoja Biopharma

“Dynamic audience interaction”

“Dynamic audience interaction was what stood out the most. Also, quality of presenters and profile of attendees, as well as very timely topics”

Arena Pharmaceuticals

 

“This is one of the best conferences I have been to that focused on how to be a better business partner and thereby how to bring real value to our organization. And that is very valuable”

Anavir Pharmaceuticals

“Building my network locally and beyond”

“Learning from other in-house counsel is so valuable, as we all deal with clients and outside counsel in a specific way. Meeting new people and building my network locally and beyond is priceless”

Takeda Pharmaceuticals

“A truly unique and invaluable space in the industry”

“In-House Impact looks set to occupy a truly unique and invaluable space in the industry, geared specifically towards General Counsels and their in-house teams within Life Sciences, furthering Legal’s role as a critical business growth enabler”

Roche Diagnostics Corporation